Upgrades
According to Argus Research, the prior rating for AstraZeneca PLC (NASDAQ:AZN) was changed from Hold to Buy. For the second quarter, AstraZeneca had an EPS of $0.86, compared to year-ago quarter EPS of $0.45. At the moment, the stock has a 52-week-high of $71.70 and a 52-week-low of $55.50. AstraZeneca closed at $66.32 at the end of the last trading period.
According to RBC Capital, the prior rating for The Toronto-Dominion Bank (NYSE:TD) was changed from Sector Perform to Outperform. In the third quarter, Toronto-Dominion Bank showed an EPS of $1.62, compared to $1.60 from the year-ago quarter. At the moment, the stock has a 52-week-high of $86.02 and a 52-week-low of $58.64. Toronto-Dominion Bank closed at $66.60 at the end of the last trading period.
For Apple Hospitality REIT Inc (NYSE:APLE), Wells Fargo upgraded the previous rating of Underweight to Equal-Weight. In the second quarter, Apple Hospitality REIT showed an EPS of $0.48, compared to $0.30 from the year-ago quarter. The stock has a 52-week-high of $18.69 and a 52-week-low of $14.29. At the end of the last trading period, Apple Hospitality REIT closed at $16.34.
For Park Hotels & Resorts Inc (NYSE:PK), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. For the second quarter, Park Hotels & Resorts had an EPS of $0.61, compared to year-ago quarter EPS of $0.16. The stock has a 52-week-high of $20.57 and a 52-week-low of $12.90. At the end of the last trading period, Park Hotels & Resorts closed at $14.22.
For Host Hotels & Resorts Inc (NASDAQ:HST), Wells Fargo upgraded the previous rating of Equal-Weight to Overweight. In the second quarter, Host Hotels & Resorts showed an EPS of $0.58, compared to $0.12 from the year-ago quarter. The current stock performance of Host Hotels & Resorts shows a 52-week-high of $21.63 and a 52-week-low of $15.10. Moreover, at the end of the last trading period, the closing price was at $18.24.
For Calithera Biosciences Inc (NASDAQ:CALA), HC Wainwright & Co. upgraded the previous rating of Neutral to Buy. In the second quarter, Calithera Biosciences showed an EPS of $1.59, compared to $3.80 from the year-ago quarter. The current stock performance of Calithera Biosciences shows a 52-week-high of $5.10 and a 52-week-low of $0.14. Moreover, at the end of the last trading period, the closing price was at $3.27.
According to Piper Sandler, the prior rating for Envista Holdings Corp (NYSE:NVST) was changed from Neutral to Overweight. Envista Holdings earned $0.48 in the second quarter, compared to $0.53 in the year-ago quarter. At the moment, the stock has a 52-week-high of $52.03 and a 52-week-low of $35.24. Envista Holdings closed at $36.60 at the end of the last trading period.
See all analyst ratings upgrades.
Downgrades
For Jowell Global Ltd (NASDAQ:JWEL), TD Securities downgraded the previous rating of Buy to Action List Buy. NoneThe stock has a 52-week-high of $25.78 and a 52-week-low of $0.96. At the end of the last trading period, Jowell Global closed at $1.23.
Consumer Edge Research downgraded the previous rating for The Hain Celestial Group Inc (NASDAQ:HAIN) from Overweight to Equal-Weight. For the fourth quarter, Hain Celestial Group had an EPS of $0.08, compared to year-ago quarter EPS of $0.39. The stock has a 52-week-high of $43.53 and a 52-week-low of $21.20. At the end of the last trading period, Hain Celestial Group closed at $21.28.
According to JMP Securities, the prior rating for Avalara Inc (NYSE:AVLR) was changed from Market Outperform to Market Perform. Avalara earned $0.02 in the second quarter, compared to $0.02 in the year-ago quarter. The stock has a 52-week-high of $129.34 and a 52-week-low of $66.39. At the end of the last trading period, Avalara closed at $91.82.
For Life Storage Inc (NYSE:LSI), Evercore ISI Group downgraded the previous rating of Outperform to In-Line. In the second quarter, Life Storage showed an EPS of $1.65, compared to $1.22 from the year-ago quarter. At the moment, the stock has a 52-week-high of $153.77 and a 52-week-low of $100.66. Life Storage closed at $134.08 at the end of the last trading period.
Wells Fargo downgraded the previous rating for Choice Hotels International Inc (NYSE:CHH) from Equal-Weight to Underweight. In the second quarter, Choice Hotels Intl showed an EPS of $1.43, compared to $1.22 from the year-ago quarter. The current stock performance of Choice Hotels Intl shows a 52-week-high of $157.00 and a 52-week-low of $108.70. Moreover, at the end of the last trading period, the closing price was at $117.57.
According to Wells Fargo, the prior rating for Hersha Hospitality Trust (NYSE:HT) was changed from Overweight to Equal-Weight. Hersha Hospitality earned $0.56 in the second quarter, compared to $0.04 in the year-ago quarter. The current stock performance of Hersha Hospitality shows a 52-week-high of $12.15 and a 52-week-low of $8.05. Moreover, at the end of the last trading period, the closing price was at $10.66.
Wells Fargo downgraded the previous rating for Diamondrock Hospitality Co (NYSE:DRH) from Overweight to Equal-Weight. For the second quarter, Diamondrock Hospitality had an EPS of $0.36, compared to year-ago quarter EPS of $0.05. At the moment, the stock has a 52-week-high of $11.14 and a 52-week-low of $7.67. Diamondrock Hospitality closed at $9.01 at the end of the last trading period.
According to Wells Fargo, the prior rating for Pebblebrook Hotel Trust (NYSE:PEB) was changed from Overweight to Equal-Weight. For the second quarter, Pebblebrook Hotel had an EPS of $0.72, compared to year-ago quarter EPS of $0.12. At the moment, the stock has a 52-week-high of $26.14 and a 52-week-low of $16.04. Pebblebrook Hotel closed at $18.35 at the end of the last trading period.
According to Citigroup, the prior rating for Aerie Pharmaceuticals Inc (NASDAQ:AERI) was changed from Buy to Neutral. Aerie Pharmaceuticals earned $0.32 in the second quarter, compared to $0.84 in the year-ago quarter. The stock has a 52-week-high of $15.21 and a 52-week-low of $4.81. At the end of the last trading period, Aerie Pharmaceuticals closed at $15.09.
According to SVB Leerink, the prior rating for Molecular Partners AG (NASDAQ:MOLN) was changed from Outperform to Market Perform. NoneThe current stock performance of Molecular Partners shows a 52-week-high of $32.04 and a 52-week-low of $5.92. Moreover, at the end of the last trading period, the closing price was at $6.43.
For Westlake Corp (NYSE:WLK), Keybanc downgraded the previous rating of Sector Weight to Underweight. In the second quarter, Westlake showed an EPS of $6.60, compared to $4.04 from the year-ago quarter. The stock has a 52-week-high of $141.19 and a 52-week-low of $89.00. At the end of the last trading period, Westlake closed at $106.97.
For LyondellBasell Industries NV (NYSE:LYB), Keybanc downgraded the previous rating of Sector Weight to Underweight. LyondellBasell Industries earned $5.19 in the second quarter, compared to $6.13 in the year-ago quarter. The current stock performance of LyondellBasell Industries shows a 52-week-high of $117.22 and a 52-week-low of $82.14. Moreover, at the end of the last trading period, the closing price was at $86.87.
Keybanc downgraded the previous rating for Dow Inc (NYSE:DOW) from Sector Weight to Underweight. For the second quarter, Dow had an EPS of $2.31, compared to year-ago quarter EPS of $2.72. At the moment, the stock has a 52-week-high of $71.86 and a 52-week-low of $48.27. Dow closed at $54.46 at the end of the last trading period.
Keybanc downgraded the previous rating for The Cooper Companies Inc (NYSE:COO) from Overweight to Sector Weight. Cooper Companies earned $3.24 in the second quarter, compared to $3.38 in the year-ago quarter. The current stock performance of Cooper Companies shows a 52-week-high of $430.67 and a 52-week-low of $284.01. Moreover, at the end of the last trading period, the closing price was at $296.57.
See all analyst ratings downgrades.
Initiations
Cantor Fitzgerald initiated coverage on Mondee Holdings Inc (NASDAQ:MOND) with an Overweight rating. The price target for Mondee Hldgs is set to $15.00. Mondee Hldgs earned $0.03 in the second quarter, compared to $0.07 in the year-ago quarter. At the moment, the stock has a 52-week-high of $13.25 and a 52-week-low of $6.80. Mondee Hldgs closed at $12.65 at the end of the last trading period.
With a Buy rating, Roth Capital initiated coverage on Battalion Oil Corp (AMEX:BATL). The price target seems to have been set at $28.00 for Battalion Oil. In the second quarter, Battalion Oil showed an EPS of $0.01, compared to $0.04 from the year-ago quarter. At the moment, the stock has a 52-week-high of $23.33 and a 52-week-low of $7.42. Battalion Oil closed at $12.70 at the end of the last trading period.
Maxim Group initiated coverage on Cryo-Cell International Inc (NASDAQ:CCEL) with a Buy rating. The price target for Cryo-Cell International is set to $12.00. In the second quarter, Cryo-Cell International showed an EPS of $0.07, compared to $0.14 from the year-ago quarter.
With a Buy rating, CL King initiated coverage on Denny's Corp (NASDAQ:DENN). The price target seems to have been set at $14.00 for Denny's. Denny's earned $0.11 in the second quarter, compared to $0.18 in the year-ago quarter. At the moment, the stock has a 52-week-high of $16.97 and a 52-week-low of $8.46. Denny's closed at $9.66 at the end of the last trading period.
With a Buy rating, Dawson James initiated coverage on Smart for Life Inc (NASDAQ:SMFL). The price target seems to have been set at $8.00 for Smart for Life. The stock has a 52-week-high of $3.25 and a 52-week-low of $0.38. At the end of the last trading period, Smart for Life closed at $0.53.
B of A Securities initiated coverage on IGM Biosciences Inc (NASDAQ:IGMS) with a Buy rating. The price target for IGM Biosciences is set to $34.00. In the second quarter, IGM Biosciences showed an EPS of $1.33, compared to $1.16 from the year-ago quarter. The stock has a 52-week-high of $35.98 and a 52-week-low of $12.67. At the end of the last trading period, IGM Biosciences closed at $18.42.
With an Outperform rating, Cowen & Co. initiated coverage on Deciphera Pharmaceuticals Inc (NASDAQ:DCPH). The price target seems to have been set at $25.00 for Deciphera Pharmaceuticals. For the second quarter, Deciphera Pharmaceuticals had an EPS of $0.60, compared to year-ago quarter EPS of $1.21. At the moment, the stock has a 52-week-high of $17.33 and a 52-week-low of $6.51. Deciphera Pharmaceuticals closed at $14.85 at the end of the last trading period.
UBS initiated coverage on Millicom International Cellular SA (NASDAQ:TIGO) with a Neutral rating. The price target for Millicom Intl Cellular is set to $16.50. For the second quarter, Millicom Intl Cellular had an EPS of $1.14, compared to year-ago quarter EPS of $0.98. At the moment, the stock has a 52-week-high of $29.66 and a 52-week-low of $12.82. Millicom Intl Cellular closed at $15.16 at the end of the last trading period.
B of A Securities initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ:XENE) with a Buy rating. For the second quarter, Xenon Pharmaceuticals had an EPS of $0.55, compared to year-ago quarter EPS of $0.51. The current stock performance of Xenon Pharmaceuticals shows a 52-week-high of $41.39 and a 52-week-low of $24.60. Moreover, at the end of the last trading period, the closing price was at $36.97.
With a Buy rating, HC Wainwright & Co. initiated coverage on Vigil Neuroscience Inc (NASDAQ:VIGL). The price target seems to have been set at $24.00 for Vigil Neuroscience. The stock has a 52-week-high of $18.27 and a 52-week-low of $2.18. At the end of the last trading period, Vigil Neuroscience closed at $8.38.
RBC Capital initiated coverage on Vivid Seats Inc (NASDAQ:SEAT) with a Sector Perform rating. The price target for Vivid Seats is set to $10.50. The current stock performance of Vivid Seats shows a 52-week-high of $12.52 and a 52-week-low of $7.02. Moreover, at the end of the last trading period, the closing price was at $8.54.
